Axa S.A. Dynavax Technologies Corp Transaction History

Axa S.A.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jul 16, 2024	BUY	$13.09 - $14.98 $2.46 Million - $2.81 Million	187,800 New	187,800 $2.63 Million
Q4 2023 Feb 14, 2024	BUY	$13.09 - $14.98 $78,540 - $89,880	6,000 Added 3.3%	187,800 $2.63 Million
Q2 2023 Aug 14, 2023	SELL	$9.85 - $13.17 $34,475 - $46,095	-3,500 Reduced 1.89%	181,800 $2.35 Million
Q1 2023 May 15, 2023	BUY	$9.44 - $11.88 $640,976 - $806,652	67,900 Added 57.84%	185,300 $1.82 Million
Q4 2022 Feb 14, 2023	BUY	$10.27 - $13.29 $901,706 - $1.17 Million	87,800 Added 296.62%	117,400 $1.25 Million
Q3 2022 Feb 14, 2023	BUY	$9.93 - $17.44 $15,888 - $27,904	1,600 Added 5.71%	29,600 $309,000
Q3 2022 Nov 14, 2022	BUY	$9.93 - $17.44 $15,888 - $27,904	1,600 Added 5.71%	29,600 $310,000
Q2 2022 Feb 14, 2023	SELL	$7.45 - $12.83 $11,920 - $20,528	-1,600 Reduced 5.41%	28,000 $352,000
Q2 2022 Aug 15, 2022	BUY	$7.45 - $12.83 $208,600 - $359,240	28,000 New	28,000 $352,000
Q4 2021 Feb 14, 2022	SELL	$13.17 - $20.94 $267,351 - $425,082	-20,300 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$9.16 - $19.83 $185,948 - $402,548	20,300 New	20,300 $390,000
Q3 2020 Nov 13, 2020	SELL	$4.32 - $11.7 $67,392 - $182,520	-15,600 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$2.94 - $9.1 $45,864 - $141,960	15,600 New	15,600 $138,000
Q3 2019 Nov 14, 2019	SELL	$2.69 - $4.85 $808,345 - $1.46 Million	-300,500 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$3.65 - $7.89 $1.1 Million - $2.37 Million	300,500 New	300,500 $1.2 Million

274

130M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.57B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.